Perimenopause and Your Skin and Hair: The Changes Nobody Mentions

Skin changes and hair thinning are among the most commonly reported and least clinically discussed perimenopause symptoms. Here is what is happening and what works.

Skin changes and hair thinning are among the most commonly experienced and least clinically discussed aspects of perimenopause. They tend to be categorised as cosmetic concerns — less medically significant than hot flushes or brain fog — and are therefore frequently dismissed or unaddressed in clinical consultations. For many women, however, visible changes to skin and hair are among the most personally distressing aspects of the transition, affecting how they feel in their bodies and in daily life in ways that other symptoms may not.

What Happens to Skin

Oestrogen is deeply involved in skin health through multiple mechanisms. It stimulates fibroblasts — the cells that produce collagen and elastin, the structural proteins giving skin its firmness, elasticity, and resistance to wrinkling. It maintains skin hydration by influencing hyaluronic acid production in skin tissue. It supports barrier function, which prevents moisture loss and protects against environmental irritants. And it influences the blood supply to skin tissue, affecting skin tone and wound healing.

As oestrogen declines during perimenopause, all of these mechanisms are affected. The most studied and most significant change is in collagen production: research consistently shows that collagen content decreases by approximately thirty percent in the first five years after menopause, with most of the decline concentrated in the perimenopause years. This collagen loss produces skin that is thinner, less firm, more prone to fine lines and wrinkles, and slower to recover from damage. Many women notice their skin becoming significantly drier, tighter, or more sensitive even if it was previously oily or unremarkable in its needs. Products that were well-tolerated for years may begin causing irritation.

What Happens to Hair

Hair follicles are highly sensitive to hormonal changes — they express receptors for both oestrogen and androgens, and the balance between these hormones directly affects the hair growth cycle. During perimenopause, declining oestrogen relative to androgens can shift follicles toward androgenic sensitivity, producing the diffuse thinning characteristic of female-pattern hair loss. The change is to the hair growth cycle: follicles spend less time in the active growth phase and more in the resting phase, reducing overall hair density rather than producing patterned baldness.

This diffuse thinning is often noticeable at the parting and temples before it is visible to others, and it can be distressing partly because of cultural associations between thick hair and health and youth. Understanding that it is hormonal rather than a sign of poor health or nutritional failure is important framing — though nutrition also matters, which is why checking ferritin (iron stores), thyroid function, and vitamin D is always appropriate when hair thinning is significant.

The thyroid connection is worth specific attention. Thyroid disorders — both hypothyroidism and hyperthyroidism — become significantly more prevalent during perimenopause, and their symptoms overlap substantially with perimenopause: fatigue, weight changes, mood changes, cognitive symptoms, and hair thinning. Missing a thyroid disorder because symptoms are attributed to perimenopause means missing a treatable condition. A thyroid function test is a reasonable and routine request for any perimenopausal woman experiencing significant hair thinning or unexplained fatigue.

Iron and ferritin deficiency are also common causes of hair thinning in perimenopausal women, particularly those with heavier menstrual bleeding. Low ferritin can produce significant hair thinning at levels technically within the normal laboratory range — a ferritin below fifty micrograms per litre is worth discussing in the context of hair thinning, even if the lab's reference range extends lower.

What Actually Helps

For skin, the interventions with the strongest evidence are topical actives with documented effects and HRT. Retinoids — vitamin A derivatives including retinol, retinal, and prescription tretinoin — have the strongest evidence base for stimulating collagen production and improving skin texture. They require consistent use over months and need to be introduced gradually to minimise irritation. Vitamin C (ascorbic acid) has good evidence for collagen synthesis stimulation and for improving pigmentation changes. Daily broad-spectrum SPF — applied consistently, not just on sunny days — is the single most evidence-supported skin health behaviour for preventing and slowing the visible effects of oestrogen decline.

HRT supports skin health systemically by restoring the hormonal environment for collagen production and hydration. Many women on HRT report significant improvements in skin quality — better hydration, reduced fine lines, improved texture — that they attribute to HRT rather than topical skincare. This systemic benefit complements topical approaches and is part of the broader case for HRT in women for whom it is clinically appropriate.

For hair: investigate and address contributory causes — thyroid, ferritin, vitamin D — first. Where these are contributing, addressing them often produces meaningful improvement. Minoxidil (available over the counter as a topical scalp treatment) has evidence for stimulating the hair growth cycle in diffuse thinning. HRT, by restoring the oestrogen-androgen balance, can slow or halt the androgenic-pattern thinning driven by perimenopause hormonal change.